TS-121

N/A

Report date: 2022/12/05 20:00:54
NME

Base Information

Drug NameTS-121
Drug Alias NameTS-121TS-1211ANC-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1b receptor antagonists
TargetsVasopressin V1b receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co LtdEmbarkNeuro Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmbarkNeuro Inc
Inactive CompaniesTaisho Pharmaceutical R&D IncTaisho Pharmaceutical Holdings Co Ltd
Active IndicationsDepressive Disorder, Major
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A